KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abercrombie & Fitch (ANF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Abercrombie & Fitch (ANF) over the last 17 years, with Q4 2025 value amounting to $605.8 million.

  • Abercrombie & Fitch's Cash & Equivalents fell 1131.71% to $605.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $605.8 million, marking a year-over-year decrease of 1131.71%. This contributed to the annual value of $772.7 million for FY2025, which is 1422.57% down from last year.
  • As of Q4 2025, Abercrombie & Fitch's Cash & Equivalents stood at $605.8 million, which was down 1131.71% from $572.7 million recorded in Q3 2025.
  • Abercrombie & Fitch's Cash & Equivalents' 5-year high stood at $1.1 billion during Q1 2021, with a 5-year trough of $257.3 million in Q4 2022.
  • Its 5-year average for Cash & Equivalents is $680.0 million, with a median of $666.3 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 7027.2% in 2022, then skyrocketed by 15239.34% in 2023.
  • Over the past 5 years, Abercrombie & Fitch's Cash & Equivalents (Quarter) stood at $865.6 million in 2021, then crashed by 70.27% to $257.3 million in 2022, then skyrocketed by 152.39% to $649.5 million in 2023, then grew by 5.17% to $683.1 million in 2024, then dropped by 11.32% to $605.8 million in 2025.
  • Its Cash & Equivalents stands at $605.8 million for Q4 2025, versus $572.7 million for Q3 2025 and $510.6 million for Q2 2025.